STERIS plc (FRA:2TG)

Market Cap	17.58B -18.9%
Revenue (ttm)	5.15B +8.7%
Net Income	678.49M +27.3%
EPS	6.88 +27.8%
Shares Out	n/a
PE Ratio	25.91
Forward PE	18.67
Dividend	2.27 (1.33%)
Ex-Dividend Date	Feb 17, 2026

Volume	n/a
Open	171.50
Previous Close	180.30
Day's Range	171.50 - 171.50
52-Week Range	162.90 - 232.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 11, 2026

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1985
• Employees: 17,937
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2TG

Financial Performance

In fiscal year 2026, STERIS's revenue was $5.94 billion, an increase of 8.73% compared to the previous year's $5.46 billion. Earnings were $782.30 million, an increase of 27.29%.

Financial numbers in USD